Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
CRAT37 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
IQCF5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
SLMAP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
OSBPL8 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NOL7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RET - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FAM170B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TGM2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC47A2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SMARCD3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC100130111 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SMTNL2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MYO9A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LRRC17 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DRG2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KDM4B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on